We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PET Manufacturer Hit for Numerous Violations
The FDA cited the University of Texas Southwestern Medical Center for significant violations at its positron emission tomography (PET) drug manufacturing facility in Dallas.